July 3rd 2024
Clinical trial for BI 3034701 is expected to evaluate the safety, tolerability, and pharmacokinetics in healthy men and overweight or obese individuals aged 18-55 years old.
The eClinical Forum Risk Based Monitoring Taskforce offers some best practices for ensuring clinical data quality.